February 28, 2010

GlaxoSmithKline has identified more than 5,500 rare diseases it potentially could target as part of...

February 28, 2010

With exception to those companies that are the first to win Food and Drug Administration...

February 25, 2010

A Pfizer executive credited with diversifying the company’s portfolio and helping create a joint venture...

February 24, 2010

Mylan had profits of $93.5 million in 2009, the generic drug maker announced Thursday in...

February 22, 2010

The Food and Drug Administration is reviewing data from a large clinical study of a...

February 22, 2010

President Barack Obama’s proposed healthcare bill may have its supporters and detractors, but one group...

February 22, 2010

Watson Pharmaceuticals had profits of $348.8 million for 2009, according to annual financial results announced...

February 21, 2010

The Food and Drug Administration hopes to accelerate the review process for generic drugs, according...

February 21, 2010

A report released over the weekend by a Senate committee linked a drug used to...

February 20, 2010

Watson Pharmaceuticals has filed a regulatory approval application with the Food and Drug Administration for...

February 16, 2010

Merck & Co. has appointed former Johnson & Johnson executive Bridgette Heller to serve as...

February 16, 2010

Teva Pharmaceutical Industries got a big boost in profits in 2009 compared with 2008, the...

February 15, 2010

On a lot of issues, the branded and generic drug industries agree about as readily...

February 10, 2010

Pfizer, Merck & Co. and Roche have made big mega-acquisitions. Eli Lilly has pumped money...

February 8, 2010

The Food and Drug Administration has approved a generic hypertension drug made by India-based Lupin...

February 7, 2010

Teva Pharmaceutical Industries has reached a settlement in a case alleging that governments had to...

February 3, 2010

Pfizer had some impressive results in the earnings report it released Wednesday, but the company...

February 1, 2010

Cephalon plans to buy a generic drug maker based in Switzerland for $590 million, the...

February 1, 2010

The Food and Drug Administration has accepted a regulatory approval application from Teva Pharmaceutical Industries...

January 28, 2010

The Food and Drug Administration has given tentative approval to a generic version of a...

January 26, 2010

Pfizer’s acquisition of Wyeth appears to be paying off for the world’s largest drug maker....

January 25, 2010

Sandoz is “confident” that it will win approval for a generic anti-clotting drug, according to...

January 24, 2010

A generic version of a gastroesophageal reflux disease drug that dissolves in the mouth doesn’t...

January 20, 2010

Sandoz has launched a generic version of a drug for schizophrenia and bipolar disorder, the...